NYSE:CRMD
CorMedix Inc Stock News
$5.84
+0.470 (+8.75%)
At Close: May 03, 2024
CorMedix Drug Candidate Lauded By FDA, Approved In The EU, Could Treat Deadly Pathogen Feared By CDC
12:00am, Friday, 02'nd Feb 2018BRIEF-Cormedix Amends Registration Rights Agreement
02:49pm, Monday, 11'th Dec 2017
* CORMEDIX SAYS ENTERED AMENDMENT TO REGISTRATION RIGHTS AGREEMENT BY AND BETWEEN CO, ELLIOTT ASSOCIATES LP, ELLIOTT INTERNATIONAL LP - SEC FILING